Here are the latest quarterly results of Biocon. For more details, see the Biocon financial fact sheet and Biocon share price and chart. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-19* |
3
Jun-19* |
3
Sep-19* |
3
Dec-19* |
3
Mar-20* |
3
Jun-20* |
3
Sep-20* |
3
Dec-20* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 7,639 | 4,808 | 15,722 | 17,481 | 15,810 | 16,713 | 17,448 | 18,510 | |
Other income | Rs m | 139 | 253 | 384 | 358 | 631 | 183 | 155 | 279 | |
Turnover | Rs m | 7,778 | 5,061 | 16,106 | 17,839 | 16,441 | 16,896 | 17,603 | 18,789 | |
Expenses | Rs m | 6,654 | 4,074 | 11,694 | 13,039 | 12,624 | 12,580 | 13,534 | 14,515 | |
Gross profit | Rs m | 985 | 1,554 | 4,703 | 4,442 | 3,186 | 4,133 | 3,914 | 3,995 | |
Depreciation | Rs m | 375 | 240 | 1,316 | 1,440 | 1,524 | 1,668 | 1,777 | 1,863 | |
Interest | Rs m | 6 | 5 | 138 | 177 | 168 | 125 | 65 | 48 | |
Profit before tax | Rs m | 743 | 1,562 | 3,633 | 3,183 | 2,125 | 2,523 | 2,227 | 2,363 | |
Tax | Rs m | 38 | 342 | 1,001 | 848 | 450 | 809 | 223 | 489 | |
Profit after tax | Rs m | 705 | 1,220 | 2,632 | 2,335 | 1,675 | 1,714 | 2,004 | 1,874 | |
Gross profit margin | % | 12.9 | 32.3 | 29.9 | 25.4 | 20.2 | 24.7 | 22.4 | 21.6 | |
Effective tax rate | % | 5.1 | 21.9 | 27.6 | 26.6 | 21.2 | 32.1 | 10.0 | 20.7 | |
Net profit margin | % | 9.2 | 25.4 | 16.7 | 13.4 | 10.6 | 10.3 | 11.5 | 10.1 | |
Diluted EPS | Rs | 1.2 | 2.0 | 4.4 | 3.9 | 2.8 | 2.9 | 3.3 | 3.1 | |
Diluted EPS (TTM) | Rs | 13.6 | 13.4 | 11.4 | 11.5 | 13.1 | 13.9 | 12.9 | 12.1 | |
![]() |
Read: Biocon 3QFY21 Result Performance Review
More Pharmaceuticals Company Quarterly Results: NEULAND LABS INDOCO REMEDIES DISHMAN PHARMA NATCO PHARMA FULFORD INDIA
Compare BIOCON With: NEULAND LABS INDOCO REMEDIES DISHMAN PHARMA NATCO PHARMA FULFORD INDIA
Compare BIOCON With: MYLAN (US) ACTAVIS (US) ADCOCK INGRAM (S. Africa) TEVA PHARMA (Israel)
Indian share markets witnessed huge selling during closing hours on Friday and ended lower.
For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.
For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.
More Views on NewsLast time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
In this video, I'll show you how to get started on the path to daily trading profits.
An Indian company founded three decades ago in a garage caught my attention...
In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.
More